Fundz

Epi Vario reported raising $135,000 in an initial SEC Form D filing, from an offering of $1.5 Million

PRIVATESep 12, 2022$135K of $1.5M raised

Amount Raised

$135,000

$135,000 sold, per SEC Form D (first sale Aug 26, 2022)

Round Type

Seed

PhiladelphiaHealthcare

Quick answer

EpiVario Inc. raised $135,000 in a Seed round, dated August 26, 2022. EpiVario Inc. is based in Philadelphia, Pennsylvania, United States.

How much did EpiVario Inc. raise?
EpiVario Inc. raised $135,000 in a Seed round on August 26, 2022.
What does EpiVario Inc. do?
EpiVario is a preclinical stage biotechnology company focusing on neuropsychiatric disorders.
Where is EpiVario Inc. based and how big is it?
EpiVario Inc. is based in Philadelphia, Pennsylvania, United States. Fundz records about 4 employees.
Who are the decision-makers at EpiVario Inc?
Fundz holds 1 contact at EpiVario Inc., including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as EpiVario Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Laguna Tech USA raised $1.5M (Seed) on October 10, 2022.
  • Hawkeye Surgical Lighting raised $750K (Seed) on October 10, 2022.
  • Focused Cryo, Inc raised $2.6M (Seed) on October 7, 2022.
  • NewcelX raised $4M (Seed) on October 7, 2022.
  • Aridis Pharmaceuticals, Inc. raised $8M on October 7, 2022.
  • Ascellus raised $100K (Seed) on October 6, 2022.

Who to call at EpiVario Inc., and when

A new round usually means EpiVario Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day EpiVario Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at EpiVario Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at EpiVario Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

EpiVario Inc.

Location

3401 GRAYS FERRY AVENUE, BUILDING 176

Philadelphia, Pennsylvania, United States

About

EpiVario is a preclinical stage biotechnology company focusing on neuropsychiatric disorders. Our co-founders, Dr. Shelley Berger and Dr. Philipp Mews, are leaders in the field of neuroepigenetics. They identified a key metabolic enzyme that functions within the nucleus of neurons to activate genes critical for long term memory. This epigenetic mechanism plays a critical role in consolidating trauma-induced fear and stress responses and drug craving associated with addiction. Thus, providing a new target for treating memory-related neuropsychiatric disorders, such as PTSD and drug and alcohol addiction, and starting with nicotine addiction.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment EpiVario Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsThomas K., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for EpiVario Inc.'s next move

See what Strategic adds

EpiVario Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.